filmov
tv
ALK Positive Lung Cancer in 2023 and Beyond: Thinking Outside the Box with Dr. Alice Shaw

Показать описание
Keynote by Dr. Alice Shaw, Global Head of Translational Clinical Oncology at Novartis Institutes for BioMedical Research.
ALK Positive Lung Cancer in 2023 and Beyond: Thinking Outside the Box with Dr. Alice Shaw
ALK Positive More Than Lung Cancer
How do ALK-inhibitors work in ALK-positive lung cancer?
What is an ALK-positive cancer?
What is treatment like for ALK-positive lung cancer?
FDA D.I.S.C.O.: Two approvals for ALK-positive non-small cell lung cancer
CNS Metastasis in ALK positive lung cancer
Living with ALK Positive lung cancer - Patients testimonial
Shaw Patterns of Resistance in ALK Positive NSCLC
Updates and unmet needs in ALK-mutated lung cancer
What is an ALK rearrangement in lung cancer?
Choosing the best ALK inhibitor for lung cancer
Exploring Treatment Options for Patients with ALK-Mutated Lung Cancer
ALK-Positive Lung Cancer
Progress in the treatment of ALK-positive non-small cell lung cancer
Dr. Christina Baik on Alectinib Versus Crizotinib in ALK-positive Lung Cancer
Treatment Access for ALK+ Lung Cancer Patients
ALK-Positive NSCLC: ALEX Trial
Targeting ALK rearrangements in non-small cell lung cancer
Second-Line Treatment for ALK-Positive NSCLC
How to maximize clinical benefits for patients with ALK-positive non-small cell lung cancer
Alecensa: Targeted Therapy for ALK-Positive Lung Cancer
ALK-Positive NSCLC
ALK-positive NSCLC: the role of treatment selection and sequencing
Комментарии